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Abstract 
Structures of a semisynthetic RNase have been obtained to a resolution of 2.0 8, at pH values of 5.2, 6.5, 7.5, and 8.8, respectively. The principle 
structural transformation occurring over this pH range is the conversion of the side chain of active site residue His-l 19 from one conformation 
k, = -43” to -57”) at low pH to another k, = + 159” to + 168”) at higher pH values. On the basis of this observation, a model is proposed that 
reconciles the disparate pK values for His-l 19 in the enzyme-substrate complex that have been deduced from kinetic studies and from proton NMR 
measurements in the presence of pseudosubstrates. 
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1. Introduction 
Active site residue His-l 19 exhibits a conformational 
mobility that is unique among the amino acid residues 
in bovine pancreatic ribonuclease A (RNase A). By rota- 
tion about its C,C, bond, the imidazole side chain can 
occupy two distinct conformations, denoted position A 
(x, = + 149” to + 168”) and position B k, = -43” to 
-60”) [l-5]. The relative occupancy of the two confor- 
mations in the crystal appears to be modulated by the 
crystallization solvent, with position A being favored in 
aqueous organic solvents ([1,2], V.S.J. de Mel, unpub- 
lished) and position B being favored in salt solutions 
[3-51. Baudet-Nessler et al. [6] found His-l 19 to be in 
position A in a fluorescent His- 12-alkylated erivative of 
RNase A crystallized from salt solutions, but, in this 
case, the imidazole ring of His-119 is stacked on the 
naphthyl moiety of the His-12 substituent. In addition, 
Harris et al. [7] have reported that a non-bonded poten- 
tial energy map for His-l 19 reveals two discrete side 
chain positions possessing energy minima; these posi- 
tions correspond to the crystallographically observed A 
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Abbreviations: RNase A, bovine pancreatic ribonuclease A; RNase 
l-l 18, polypeptide consisting of residues 1 through 118 of RNase A; 
RNase 11 I-124, tetradecapeptide consisting of residues 11 l-124 of 
RNase A; RNase Ill-124nyr-1201, tetradecapeptide in which Phe-120 
is replaced by Tyr; RNase 1-118:111~124, noncovalent complet of 
RNase 1-l 18 and RNase 11 I-124; (F120Y), noncovalent complex of 
RNase I-118 and RNase 111-124pyr-1201 in which Phe-120 is re- 
placed by Tyr; UpA, uridylyl-3’,5’-adenosine; UpcA, UpA in which the 
5’ oxygen of the ribose moiety of the adenosine is replaced by a meth- 
ylene group. 
and B positions and are linked by a low energy pathway. 
Recently, a high resolution 2D NMR study of RNase A 
has revealed that position B also predominates in solu- 
tion at pH 4.0 [S]. The equilibrium between the two 
conformations in solution appears to be a function of 
pH, with position B being favored at low pH values and 
position A being favored at high pH values [9]. 
Given the central role ascribed to His-l 19 in the cata- 
lytic mechanism of RNase [10-l 31, the possibility that its 
dual positioning has mechanistic significance is an at- 
tractive idea. In their studies of the active site dynamics 
of RNase A, Briinger et al. [14] noted that His-119 un- 
derwent dihedral-angle transitions in some of the simula- 
tions and suggested that this freedom of movement 
might be important for the catalytic mechanism. Mod- 
elling studies [15] have revealed, however, that His-l 19 
is positioned equally well to participate in both the 
transphosphorylation and hydrolytic reactions catalyzed 
by the enzyme whether it is in position A or position B. 
As yet, no experimental verification or disproof of a 
linkage between the dual conformations of His-l 19 and 
the mechanism of action of the enzyme has been forth- 
coming. 
A fruitful system for the study of RNase has been the 
fully active semisynthetic noncovalent complex formed 
between RNase l-l 18 and a synthetic 1Cresidue peptide 
containing the C-terminus of the molecule, that is, resi- 
dues 111-124 [16,17] (Fig. 1). The redundant residues in 
RNase 111-124 are needed to achieve good binding and 
full activity. The six C-terminal residues are unique to 
the peptide, however, allowing study of the possible roles 
played by these residues in generating the catalytic effi- 
ciency and substrate specificity of the enzyme through 
the chemical synthesis of structural variants. Semisyn- 
thetic complexes between RNase l-l 18 and a large num- 
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ber of structural analogs of RNase Ill-124 have been 
prepared and characterized kinetically [ 17-241 and by 
proton NMR measurements [25-271. In addition, high- 
resolution crystal structures have been determined for 
several catalytically modified analogs [15,28] as well as 
for the fully active parent structure [3]. 
We report here on the positioning of His-l 19 in four 
2.0-A structures of Fl20Y obtained at pH values of 5.2, 
6.5, 7.5, and 8.8, respectively. Fl20Y is an analog in 
which the phenylalanine present at position 120 in the 
parent structure has been replaced by a tyrosine, result- 
ing in an enzyme that is fully active or hyperactive, de- 
pending upon the substrate [19]. Crystals of this analog 
were used for the pH study because they proved to be 
more robust than crystals of the parent complex toward 
changes in the acidity of the mother liquor. We have 
found that the positioning of His-l 19 in the crystal is 
modulated by the pH of the mother liquor, with a pre- 
dominant occupancy of position B converting to a pre- 
dominant occupancy of position A over the pH range of 
5.2 to 8.8. 
2. Experimental 
2.1. Preparation of RNase 1-118 and RNase Ill-124[Tyr-1201 
RNase l-l 18 was prepared from RNase A (Type II-A, Sigma) by 
successive peptic and carboxypeptidase A digestions of the protein [16], 
and characterized as previously described [28,29]. RNase 11 l-124ryr- 
1201 was synthesized by the Wayne State University Macromolecular 
Core Facility and purified as previously described for other peptides 
[29,30]. Stock solutions of the peptide were characterized and standard- 
ized by amino acid analysis of acid hydrolysates of aliquot samples. 
2.2. Crystallization 
Crystals of F120Y were grown from ammonium sulfate/cesium chlo- 
ride salt solutions buffered at pH 5.2 as described earlier [25,29,31]. For 
the determination of the structure at pH 5.2, CsCl was removed by 
transferring individual crystals into a stabilizing buffer of 80% satu- 
rated ammonium sulfate, 0.1 M ammonium acetate, pH 5.2. The crystal 
was then soaked between 2 and 4 h, with several changes of solution, 
before being mounted in a glass capillary in the usual way. For the 
determination of the structures at pH values of 6.5,7.5, and 8.8, crystals 
were transferred to 80% saturated ammonium sulfate that had been 
adjusted to the appropriate pH value. When crystals of the parent 
phenylalanine-120-containing enzyme were shifted from 80% ammo- 
nium sulfate, pH 5.2, to 80% ammonium sulfate, pH 7.5, they rapidly 
deteriorated. Consequently, the pH study was carried out with the fully 
active Tyr-120 analog, which seemed better able to stand the shock of 
the pH change. All the crystals deteriorated noticeably if stored in the 
absence of CsCl longer than a week. 
2.3. Data collection 
Area detector data were collected for the structures at pH values of 
7.5 and 8.8 on a Siemens system employing a three-axis camera, a 
PCS-driven controller, and the XENGEN software package [32] sup- 
ported on a VAX 3600 minicomputer, using procedures identical to 
those used for the determination of the structure of Fl20Y at pH 5.2 
[28]. For the structure at pH 6.5, area detector data were collected at 
room temperature on the same Siemens system, but employing a four 
circle goniometer. 
2.4. Refinement 
The crystals belong to the same space group as the parent molecule 
[3], and, therefore, the refined coordinates for this molecule (Protein 
Data Bank 1331, entry ISRN) were used as the initial model. Rigid body 
refinement was followed by simulated annealing performed with the 
X-PLOR urogram 1341. Further refinement was carried out using the 
program PRGLSQ i35j while checking the stereochemistry graphkally 
using the program TOMlFRODO [36,37]. 
Water molecules were added and retained if the electron density 
peak, (1) appeared in F,-F, maps at greater than 3.2 6, (2) appeared 
in 2 F,-F, maps at greater than 0.7 cr and (3) the position was within 
hydrogen bonding distance of an appropriate atom. 
In the final stage of the refinement, a few cycles of PROFFT [38,39] 
and B-refinement in X-PLOR were used. 
To determine the relative occupancy by His-l 19 of positions A and 
B at each pH value, independent refinement of the two structures with 
the side chain exclusively in position A or in position B was first carried 
out. In each case, His-l 19 side chain atoms were assigned full occu- 
pancy and the model subjected to a few cycles of PROLSQ refinement. 
2 F,-F, maps were computed to check the electron density for the 
imidazole rings and to verify the refined A and B positions. Then the 
side chain atoms of His-12, His-105 and His-l 19 were removed, substi- 
tuted by alanine, and a few cycles of PROLSQ refinement were carried 
out before computing F,-F, maps. 
Integration of the difference electron density was performed by sum- 
ming density that was greater than 2a above background at all grid 
ooints within 1.9 A of the CD2. NE2. and CEI atoms of the imidazole 
;ing. The 1.9-A cutoff and the three ring atoms were chosen to exclude 
from the calculation any density common to the two conformations as 
well as any density from the C, carbon or beyond. The relative occu- 
pancy of the alternate positions of His-l 19 was determined by calculat- 
ing the ratio of the integrated densitites for the two positions. 
3. Results and discussion 
As the pH of the 80% saturated (NH&SO, surround- 
ing the crystals of Fl20Y is progressively raised from 
Table 1 
Data collection and refinement 
Statistics” F120Y at pH 5.2 F120Y at pH 6.5 F120Y at pH 7.5 F120Y at pH 8.8 
Unit cell (A) a = b = 68.15 a = b = 67.77 a = b = 67.81 a=b=67.13 
c = 65.15 c = 65.03 c = 65.01 c 64.82 = 
y= 120 y= 120 y= 120 y= 120 
Reflections used 11,776 11,722 10,406 9,497 
Resolution 5.0-2.0 5.0-2.0 5.0-2.0 5.0-2.0 
R after PROLSQ 0.193 0.182 0.178 0.186 
R after X-PLOR B refinement 0.184 0.168 0.169 0.175 
RMS bonds 0.025 0.021 0.020 0.020 
RMS w angle 1.9 1.6 1.6 1.5 
“All structures were determined with crystals grown from 1.3 M ammonium sulfate, 3.0 M cesium chloride, pH 5.2. For structure determinations 
above pH 5.2, crystals were soaked at the appropriate pH value as described in section 2. The space group is P3221. 
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l-------120-121-124 
RIBONUCLEASE A RNASE l-120 RNASE 121-124 
(0.5% ACTIVE) 
CARBOXYPEPTIDASE A 
RNASE l-118:111-124 
(NONCOVALENT COMPLEX) 
RNASE 1-118 
(NO DETECTABLE 
ACTIVITY) 
I RNASE 111-124 I 
157 
SYNTHETIC PEPTIDE 
Fig. 1. Preparation and assembly of RNase 1-l 18:11 I-124. The schematic diagram shows the preparation of RNase l-1 18 by proteolytic digestion 
and its assembly with a chemically synthesized 11 I-124 peptide into a noncovalent complex (which is fully active when no amino acid replacements 
have been made). 
5.2 to 7.5 to 8.8, the unit cell dimensions diminish signifi- 
cantly (Table 1). Nonetheless, structures at the higher pH 
values refined readily when subjected to the rigid body 
refinement procedures described in section 2. The 
isoionic point of RNase A occurs at pH 9.6 [lo], so the 
net positive charge on the molecule is declining over the 
pH range 5.2-8.8, a change that might be expected to 
allow greater compression of the structure. More muted 
unit cell expansions or contractions with changes in pH 
have been seen with other protein crystals [4&43]. 
As the pH increases from 5.2 to 6.5 and then to 7.5, 
small, but significant, increases occur in the occupancy 
of position A by the side chain of His-l 19 (Fig. 2, Table 
2). These shifts are then followed by a more dramatic 
increase in the occupancy of position A as the pH is 
raised to 8.8 (Table 2). An additional structural change 
accompanying the rise in pH from 7.5 to 8.8 is the disap- 
pearance of the sulfate dianion from the active site. This 
loss of the sulfate ion may contribute to the greater de- 
gree of conformational shift seen upon going from 
pH 7.5 to pH 8.8. In contrast, no consistent change in 
Table 2 
Variation of the occupancy of His-119 side chain conformers as a 
function of pH; comparison with two uniquely positioned histidine 
residues, His-12 and His-105” 
PH His-105 His-12 His-l 19 in His-l 19 in Position A/ 
position A position B Position B 
5.2 9,864b 11,547 3,630 (0.42)’ 5,021 (0.58) 0.7 
6.5 11,215 12,658 3,271 (0.50) 3,233 (0.50) 1.0 
7.5 8,445 11,130 3,197 (0.63) 1,866 (0.37) 1.7 
8.8 9,631 12,819 8,529 (0.76) 2,681 (0.24) 3.2 
“Calculated as described under Section 2. 
bTotal electron density above 2olatom. 
‘Fraction of side chain in this position. 
occupancy with an increase in pH is seen with the 
uniquely positioned side chains of active site residue 
His-12 or of His-105, considered to be a ‘normal’ histid- 
ine residue [lo, 1 l] (Table 2). 
The total electron density found for the side chain of 
His-l 19, that is, the sum of the electron density seen for 
positions A and B, is comparable at both pH 5.2 and 8.8 
to that found for His-12 and His-105 (Table 2). At the 
intermediate pH values of 6.5 and 7.5, however, where 
kc,, values are maximal [44], the total electron density for 
His-l 19 is much smaller. No third conformation is evi- 
dent at these pH values. Such a decline could indicate a 
greater side chain mobility at these pH values than at 
pH 5.2 or 8.8. The temperature factors for the side chain 
atoms are not increased in this pH range, however. 
As judged from the difference distance matrix [45,46] 
for the C, atoms of the pH 5.2 and pH 8.8 structures, no 
backbone structural changes such as the movement of 
the loop containing residues 65-72, which is seen in sev- 
eral catalytically modified analogs [15,28], are evident 
over the pH range of 5.2 to 8.8. 
Analysis of the structure of RNase A by 2D NMR 
techniques has revealed the existence in solution also of 
the two conformations corresponding to positions A and 
B for the side chain of His-l 19 [8]. Moreover, the occu- 
pancy of the two conformations is modulated by the pH 
of the solution in this case as well, with the occupancy 
of position A being favored at higher pH values [9]. 
We propose that the equilibrium between the two con- 
formations observed for the side chain of His-l 19, hav- 
ing quite similar energy levels, can be modulated by a 
moderate change in conditions, such as a variation in the 
local electrostatic potential. At pH 5.2, both the positive 
charge on the side chain of His-l 19 itself and the high net 
positive charge on the molecule as a whole will favor 
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(A) 
(B) 
(D) 
Fig. 2. Electron density for histidine-119 in F120Y at various pH values. The F,-F, density peaks for the imidazole ring of his-l 19 in Fl20Y contoured 
at 2~: panel A, pH 5.2; panel B, pH 6.5; panel C, pH 7.5; and panel D, pH 8.8. The conformations denoted position A and position B are shown 
schematically in each panel. 
occupancy of position B. As the pH increases, both the 
positive charge on His-l 19 and the net positive charge on 
the molecule will decrease, allowing progressively greater 
occupancy of position A. Moreover, we propose that 
position A, but not position B, is the catalytically compe- 
tent conformation for the hydrolysis of cyclic phosphate 
substrates. When the side chain of His-l 19 occupies po- 
sition A, the molecule is an active enzyme, but when it 
occupies position B, the molecule is inactive. 
Such a model can reconcile a major discrepancy be- 
tween the values for the pK of the imidazole ring of 
His-l 19 assigned on the basis of kinetic measurements 
and those obtained from proton NMR studies in the 
presence of pseudosubstrates. On the basis of the pH 
dependence of the kinetic parameters for the hydrolysis 
of cytidine 2’,3’-cyclic phosphate, Findlay et al. proposed 
that the catalytically competent form of the enzyme con- 
tained one positively charged histidine and one neutral 
histidine at the active site [47]. To account for the occur- 
rence of the maximal value of k,,, at pH 7.00, it was 
necessary to assign a pK value of 8.10 to the more basic 
dissociating group at the active site in the enzyme- 
substrate complex [44]. However, proton NMR meas- 
urements of RNase A in the presence of UpcA, a dinucle- 
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otide phosphonate analog of UpA that binds well to 
RNase, but cannot be hydrolyzed, owing to the replace- 
ment of the S-ribosyl oxygen of the adenosine by a meth- 
ylene group, subsequently provided pK values of 6.1 and 
5.8 for the side chains of His- 12 and His- 119, respectively 
[48]. It might be argued that replacement of the S-ribosyl 
oxygen with a carbon atom could perturb the pK value 
of His-l 19 significantly. Similar results were obtained, 
however, using the analog, 2’-deoxy-2’-fluorouridilyl 
(3’-5’) adenosine, which also binds well, and contains the 
5’-ribosyl oxygen, but cannot be hydrolyzed owing to the 
replacement of the 2’-hydroxyl group with a fluorine 
atom [49]. With this analog bound, the corresponding pK 
values for His-12 and His-l 19 were found to be 6.60 and 
6.71, higher than the values obtained with UpcA, but still 
far from the value of 8.10 proposed for His-l 19 by 
Herries et al. [44]. 
If, however, there is a progressively greater occupancy 
of the catalytically competent conformation for His-l 19 
(position A) occurring over the pH range of 5.2 to 8.8, 
this event could partially compensate for the progressive 
decline in the required combination of one positively 
charged histidine and one neutral histidine, which is also 
occurring over much of this pH range. As these two 
factors have countervailing effects on the magnitude of 
k,,,, kinetic studies would measure the algebraic sum of 
the ‘pK’ for the pH-dependent conversion from position 
B to position A, an activating conversion, and the actual 
pK for the dissociation of the proton from the more basic 
imidazole ring, an inactivating conversion. As a result, 
the pK of His-l 19 in the enzyme-substrate complex 
would be assigned an erroneously high value. 
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